Vivos Inc (RDGL)

$0.06 0.00 (-1.55%)
Market Cap 28.24M
Revenue (ttm) 70,000.00
Net Income (ttm) -3.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,385.71%
Debt to Equity Ratio 0.00
Volume 922,000
Avg Vol 1,253,724
Day's Range N/A - N/A
Shares Out 493.74M
Stochastic %K 11%
Beta -0.75
Analysts Strong Buy
Price Target N/A

Company Profile

Vivos Inc., a radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States. The company develops RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing PLGA-g-PEG polymers; PrecisionGel, a hydrogel po...

Industry: Medical Devices
Sector: Healthcare
Phone: 509 222 2222
Address:
1030 N Center Parkway, Suite N288, Kennewick, United States
Tburns15
Tburns15 Jul. 3 at 3:09 PM
$RDGL ChatGPT tells me that it's 70% confident on an approval. It would be nice.
3 · Reply
HATELIBERALS
HATELIBERALS Jul. 2 at 11:53 PM
$RDGL Any information on what is happening in India? Also, Did that doctor ever publish his study? If not -- does anyone know why?
3 · Reply
PosCashFlo
PosCashFlo Jul. 2 at 10:59 PM
$RDGL
0 · Reply
Buster147
Buster147 Jul. 2 at 12:54 PM
$RDGL The "Day 30" Rule: The statutory calendar clock for an IDE review runs for 30 consecutive calendar days from receipt (June 5). It does not stop for mid-review holidays or weekends. Friday, July 3rd is only Day 28 of your review cycle.Only the End Date Shifts: The federal weekend/holiday rule only applies if the final deadline (Day 30) lands on a non-working day. Because Day 30 is Sunday, July 5th, the deadline rolls over to the next business day, which is Monday, July 6.The FDA's Action Window: Practically, because the FDA is closed Friday through Sunday, reviewers must issue their decision (Approval, Conditional Approval, or Disapproval) and send the email notification by the end of the day on Monday, July 6.
2 · Reply
Buster147
Buster147 Jul. 2 at 12:05 PM
$RDGL The FDA has until Monday the 6th to provide their response because of holiday weekend and federal rules and regulations. I agree they should provide response today to get it off their desk but .......
3 · Reply
anderson800
anderson800 Jul. 2 at 10:43 AM
$RDGL Actually, with Friday being a federal holiday we know today. FDA is not going to work Friday-Sunday. If I were Vivos and had not heard yet, I'd be calling my FDA contact person today.
0 · Reply
PosCashFlo
PosCashFlo Jul. 2 at 10:25 AM
$RDGL so the 5th falls on a Sunday. News on Monday unless there is no approval and they will drag it out a bit. Kinda like last time.
0 · Reply
Fireballmillionaire
Fireballmillionaire Jul. 2 at 12:24 AM
$RDGL should have news by July 21st ish...
2 · Reply
UWB67
UWB67 Jul. 1 at 9:45 AM
$RDGL About ONE trading day left until the US FDA's decision to either approve or provide more feedback on Vivos' EFS IDE application (submitted 5 June 2026) to begin human clinical trials with the Mayo Clinic. Vivos' team includes a top tier regulatory team that has maintained global elite status for many years! https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-OTCQB-RDGL-submits-Early-Feasibility-Investigational-Device-Exemption-IDE-application-to-the-US-Food-and-Drug-?id=524114 Vivos obtaining US FDA approval to begin human trials in the US WILL indicate that the data from the human trials in India is STRONG supporting Vivos' claim that RadioGel is a SAFE and EFFECTIVE treatment for solid tumors. $1+! Organically! GO VIVOS GO!! 🤞🙌👏🐂
0 · Reply
UWB67
UWB67 Jun. 30 at 12:19 PM
$RDGL About THREE trading days left until the US FDA's decision to either approve or provide more feedback on Vivos' EFS IDE application to begin human clinical trials with the Mayo Clinic. https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-OTCQB-RDGL-submits-Early-Feasibility-Investigational-Device-Exemption-IDE-application-to-the-US-Food-and-Drug-?id=524114 $1+! Organically! GO VIVOS GO!! 🤞👏🙌🐂
1 · Reply
Latest News on RDGL
No data available.
Tburns15
Tburns15 Jul. 3 at 3:09 PM
$RDGL ChatGPT tells me that it's 70% confident on an approval. It would be nice.
3 · Reply
HATELIBERALS
HATELIBERALS Jul. 2 at 11:53 PM
$RDGL Any information on what is happening in India? Also, Did that doctor ever publish his study? If not -- does anyone know why?
3 · Reply
PosCashFlo
PosCashFlo Jul. 2 at 10:59 PM
$RDGL
0 · Reply
Buster147
Buster147 Jul. 2 at 12:54 PM
$RDGL The "Day 30" Rule: The statutory calendar clock for an IDE review runs for 30 consecutive calendar days from receipt (June 5). It does not stop for mid-review holidays or weekends. Friday, July 3rd is only Day 28 of your review cycle.Only the End Date Shifts: The federal weekend/holiday rule only applies if the final deadline (Day 30) lands on a non-working day. Because Day 30 is Sunday, July 5th, the deadline rolls over to the next business day, which is Monday, July 6.The FDA's Action Window: Practically, because the FDA is closed Friday through Sunday, reviewers must issue their decision (Approval, Conditional Approval, or Disapproval) and send the email notification by the end of the day on Monday, July 6.
2 · Reply
Buster147
Buster147 Jul. 2 at 12:05 PM
$RDGL The FDA has until Monday the 6th to provide their response because of holiday weekend and federal rules and regulations. I agree they should provide response today to get it off their desk but .......
3 · Reply
anderson800
anderson800 Jul. 2 at 10:43 AM
$RDGL Actually, with Friday being a federal holiday we know today. FDA is not going to work Friday-Sunday. If I were Vivos and had not heard yet, I'd be calling my FDA contact person today.
0 · Reply
PosCashFlo
PosCashFlo Jul. 2 at 10:25 AM
$RDGL so the 5th falls on a Sunday. News on Monday unless there is no approval and they will drag it out a bit. Kinda like last time.
0 · Reply
Fireballmillionaire
Fireballmillionaire Jul. 2 at 12:24 AM
$RDGL should have news by July 21st ish...
2 · Reply
UWB67
UWB67 Jul. 1 at 9:45 AM
$RDGL About ONE trading day left until the US FDA's decision to either approve or provide more feedback on Vivos' EFS IDE application (submitted 5 June 2026) to begin human clinical trials with the Mayo Clinic. Vivos' team includes a top tier regulatory team that has maintained global elite status for many years! https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-OTCQB-RDGL-submits-Early-Feasibility-Investigational-Device-Exemption-IDE-application-to-the-US-Food-and-Drug-?id=524114 Vivos obtaining US FDA approval to begin human trials in the US WILL indicate that the data from the human trials in India is STRONG supporting Vivos' claim that RadioGel is a SAFE and EFFECTIVE treatment for solid tumors. $1+! Organically! GO VIVOS GO!! 🤞🙌👏🐂
0 · Reply
UWB67
UWB67 Jun. 30 at 12:19 PM
$RDGL About THREE trading days left until the US FDA's decision to either approve or provide more feedback on Vivos' EFS IDE application to begin human clinical trials with the Mayo Clinic. https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-OTCQB-RDGL-submits-Early-Feasibility-Investigational-Device-Exemption-IDE-application-to-the-US-Food-and-Drug-?id=524114 $1+! Organically! GO VIVOS GO!! 🤞👏🙌🐂
1 · Reply
anderson800
anderson800 Jun. 29 at 2:20 PM
$RDGL I'm not really excited at all. This has dragged on so long that at this point I could imaging almost anything happening and over the past year have made so many other stock investments that this would be nice but even if it went horribly wrong it wouldn't upset me that bad. One thing I would say is that if it does not get approved, I would say that Dr. K should hand in his resignation. I would say a NO at this point would be a complete failure on his part. 🎤
6 · Reply
UWB67
UWB67 Jun. 29 at 9:40 AM
$RDGL LESS THAN ONE WEEK until the US FDA's decision to either approve or provide more feedback on Vivos' EFS IDE application to begin human clinical trials with the Mayo Clinic. https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-OTCQB-RDGL-submits-Early-Feasibility-Investigational-Device-Exemption-IDE-application-to-the-US-Food-and-Drug-?id=524114 $1+! Organically! GO VIVOS GO!! 🤞👏🙌🐂
1 · Reply
bud63
bud63 Jun. 28 at 11:46 PM
$RDGL below 0.06 days before an important event is USUALLY a bad sign ,but we’ll see ,like a said I didn’t think it would be trading much above 0.06 but dropping below took a little confidence from me.
1 · Reply
UWB67
UWB67 Jun. 25 at 12:07 PM
$RDGL NASTY DEVILS that want to see Vivis and RadioGel fail after Vivos provided more time to so many human and pet lives via RadioGel. RadioGel is REVOLUTIONARY! $1+! ORGANICALLY! GO VIVOS GO!! 🤞🙌👏🐂
1 · Reply
UWB67
UWB67 Jun. 25 at 12:03 PM
$RDGL Vivos' goal was ALWAYS to submit an EFS IDE to the FDA to begin human trials in the US. Do your due dilligence: Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™GlobeNewswire | 09/20/2021: https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-Files-Early-Feasibility-IDE-Application-with-FDA-for-Radiogel?id=321527 EFS IDE APPROVAL will be a HUGE milestone for Vivos. DCGI (India) APPROVAL to conduct tests in humans towards commercialization in India will be a HUGE milestone for Vivos. $1+. Organically. GO VIVOS GO!! 🤞👏🙌👏🤞🐂
0 · Reply
PosCashFlo
PosCashFlo Jun. 25 at 11:20 AM
$RDGL maybe they should have started with the efs all along.
3 · Reply
Richbagholderr
Richbagholderr Jun. 24 at 7:22 PM
$RDGL lol soon .03
1 · Reply
UWB67
UWB67 Jun. 24 at 4:02 PM
$RDGL "...interest in Vivos’ product portfolio and market potential continues to grow..." - Vivos PR 5 June 2026. https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-OTCQB-RDGL-submits-Early-Feasibility-Investigational-Device-Exemption-IDE-application-to-the-US-Food-and-Drug-?id=524114 $1+. Organically. GO VIVOS GO!! 🤞👏🙌🐂
0 · Reply
UWB67
UWB67 Jun. 24 at 3:44 PM
$RDGL Investors (to include INSTITUTIONAL investors) have likely taken a wait and see approach with the pending US FDA decision on Vivos' EFS IDE application to begin human clinical trials in the US. IF the FDA approves Vivos' EFS IDE, one of the positive consequences will likely be PRs not related to FDA news having noticeable positive impacts on the share price. $1+. Organically. GO VIVOS GO!! 👏🙌🤞🐂
1 · Reply
Techallure
Techallure Jun. 23 at 4:32 PM
$OTLC and $RDGL A power packed $1-$2 punch Be prepared Bein.. repaired
6 · Reply
Dumbdumb4ever
Dumbdumb4ever Jun. 22 at 2:51 PM
$RDGL what’s everyone’s price targets by EOY and why.
4 · Reply
PosCashFlo
PosCashFlo Jun. 22 at 10:36 AM
$RDGL “The Global Solid Tumor Market: Solid tumors make up approximately 90% of all human cancer cases (encompassing lung, breast, prostate, colorectal, pancreatic, and head/neck cancers). The global market for solid tumor treatments is valued well over $150 Billion to $200 Billion annually and is growing rapidly as advanced targeted therapies emerge.”
0 · Reply